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ABSTRACT Damage-induced SOS mutagenesis requir-
ing the UmuD*C proteins occurs as part of the cells’ global
response to DNA damage. In vitro studies on the biochemical
basis of SOS mutagenesis have been hampered by difficulties
in obtaining biologically active UmuC protein, which, when
overproduced, is insoluble in aqueous solution. We have
circumvented this problem by purifying the UmuD*2C complex
in soluble form and have used it to reconstitute an SOS lesion
bypass system in vitro. Stimulated bypass of a site-directed
model abasic lesion occurs in the presence of UmuD*2C,
activated RecA protein (RecA*), b-sliding clamp, g-clamp
loading complex, single-stranded binding protein (SSB), and
either DNA polymerases III or II. Synthesis in the presence of
UmuD*2C is nonprocessive on damaged and undamaged DNA.
No lesion bypass is observed when wild-type RecA is replaced
with RecA1730, a mutant that is specifically defective for
Umu-dependent mutagenesis. Perhaps the most noteworthy
property of UmuD*2C resides in its ability to stimulate both
nucleotide misincorporation and mismatch extension at ab-
errant and normal template sites. These observations provide
a biochemical basis for the role of the Umu complex in
SOS-targeted and SOS-untargeted mutagenesis.
Escherichia coli normally replicates its DNA accurately, but the
fidelity of replication decreases dramatically after cells are
exposed to a variety of DNA-damaging agents that induce the
SOS response (1–3). Given a choice, E. coli will evoke a
damage avoidance pathway that in all likelihood involves
polymerase strand switching to a nondamaged DNA template
(4, 5). Nevertheless, situations arise where the DNA replica-
tion machinery encounters a lesion and the only recourse is the
direct replication of the damaged template.
Genetic characterization of the error-prone translesion
DNA synthesis pathway shows that it depends on the UmuD92C
complex, activated RecA protein (RecA*) and DNA polymer-
ase (pol) III (6–10). A prevailing model for translesion DNA
synthesis, based on genetic experiments, suggests that it can be
separated into two steps: nucleotide misincorporation directly
opposite the lesion, believed to require pol III and RecA (11,
12), and lesion bypass believed to involve pol III and UmuD9C
proteins (12–14).
A major roadblock in the path toward understanding the
phenomenon of Umu-dependent translesion DNA synthesis
has been the inability to purify biologically active UmuC. By
using a denatured-renatured form of UmuC, Echols and
colleagues (15) were able to purify UmuC and demonstrate
that together with UmuD9 and RecA*, DNA pol III was able
to facilitate limited translesion DNA synthesis of a synthetic
abasic site (16). We recently have succeeded in purifying the
native UmuD92C complex directly, in soluble form (17). We
showed that this complex binds cooperatively to single-
stranded DNA (17), having similar affinities to damaged and
undamaged DNA, and effectively blocks recombinational
strand exchange in vitro (W. M. Rehrauer, I.B. R.W., M.F.G.,
and S. C. Kowalczykowski, unpublished data). In the present
study, we use the soluble UmuD92C complex to reconstitute an
in vitro lesion bypass assay dependent on UmuD92C and RecA*.
A key finding is that in the presence of UmuD92C, the fidelity
of DNA synthesis is compromised markedly at both damaged
and undamaged template sites, thus providing a framework for
studying the biochemical mechanisms governing SOS targeted
and untargeted mutagenesis.
MATERIALS AND METHODS
Materials. The following reagents were all purchased: T4
polynucleotide kinase (United States BiochemicalyAmer-
sham), T4 DNA ligase (Promega), EcoRI restriction enzyme
(New England Biolabs), E. coli single-stranded binding protein
(SSB; Pharmacia), ultrapure ATP and dideoxynucleoside
triphosphates (Pharmacia), and [g-32P]ATP (4000 Ciymmol; 1
Ci 5 37 GBq) (ICN). Purification of pol III and its accessory
proteins (18) and pol II (19) were carried out as described.
RecA protein and pol I antibody were generous gifts from
Stephen Kowalczykowski (University of California, Davis) and
Lawrence Loeb (University of Washington, Seattle), respec-
tively. The abasic (1,4-anhydro-2-deoxy-D-ribitol) phos-
phoramimide was synthesized as described (20).
Purification of UmuD*2C Complex. Purification was carried
out as reported (17) with the following modifications: after
polyetheleneimine precipitation, proteins were extracted by
stirring the pellet in R-buffer (20 mM TriszHCl, pH 7.5y0.1
mM EDTAy1 mM DTTy20% glycerol) containing 1 M NaCl.
Ammonium sulfate was added to reach 50% of saturation,
followed by centrifugation of the suspension. The pellet was
dissolved in R-buffer containing 1 M NaCl, dialyzed against
R-buffer with 1 M NaCl, followed by a second ammonium
sulfate precipitation step in which UmuD92C complex precip-
itated at 30% saturation. The spun pellet was again dissolved
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in R-buffer with 1 M NaCl and dialyzed against R-buffer
containing 50 mM NaCl before chromatography using DEAE
and phosphocellulose as described (17). Phosphocellulose
fractions containing UmuD92C were concentrated and applied
seperately onto either Superdex 75 (17), Sephadex G100, or
Sephadex G150 columns (Pharmacia) and eluted in R-buffer
containing 1 M NaCl, resulting in a purity of .95%.
PrimeryTemplate Construction. All oligonucleotides were
synthesized on an Applied Biosystems model 392 DNAyRNA
synthesizer. The template used in the replicative bypass assay,
a 7.2-kb linear single-stranded DNA with an abasic lesion
located 50 bases from the 59 end, was constructed as described
(16). Two 59-end 32P-labeled 30-mers were used as primers. In
the ‘‘running-start’’ assay, the first primer is annealed to the
template such that its 39 end is 46 nt from the lesion. In the
‘‘standing-start’’ assay, the 39 end of the primer is located one
base before the abasic lesion.
Replicative Bypass Assay. The reaction mixture (10 ml)
contains 20 mM TriszHCl (pH 7.5), 8 mM MgCl2, 5 mM DTT,
0.1 mM EDTA, 25 mM sodium glutamate, 1 mM ATP, and 4%
(volyvol) glycerol. Running-start reactions were performed as
follows: 2 nM primed DNA substrate was incubated for 2 min
at 37°C with 40 nM b protein dimer, 10 nM g-complex, 1 mM
RecA, 200 nM UmuD92C complex, and 100 mM each of dATP
and dCTP. SSB (300 nM as tetramer) was then added to the
mixture and incubated for another 2 min. Replication was
initiated by addition of dGTP and dTTP (100 mM each) and
either pol III core, pol III a-subunit, or pol II, at concentra-
tions between 0 and 20 nM. Reactions were carried out at 37°C
for 10 min, then quenched by adding 20 ml EDTA (20 mM) in
95% formamide. The product DNA was heat denatured run on
a 10% polyacrylamide denaturing gel. Replication products
were quantitated by using a PhosphorImager (Molecular Dy-
namics). Standing-start reactions were carried out in a similar
manner as running-start reactions, except that all four dNTPs
were added after preincubation with UmuD92C, RecA, SSB and
b,g-complex.
RESULTS
Studies on the biochemical basis of SOS-induced mutagenesis
have been hampered by the absence of a reconstituted in vitro
assay using purified lesion bypass proteins. We now report on
the reconstitution of such an assay by using all of the compo-
nents of the mutasome, UmuD92C, RecA*, and pol III.
Reconstituting Lesion Bypass in Vitro By Using Purified
UmuD*2C, RecA, SSB, and Components of Pol III Holoenzyme.
A linearized M13 DNA template containing a single, site-
directed abasic lesion was copied by using different combina-
tions of pol III core, pol III accessory proteins (b,g-complex),
RecA, SSB, and UmuD92C (Fig. 1 Left). The primer-template
(Fig. 1 Upper) was designed to permit loading of the b
processivity clamp by the g-complex (21) and to allow binding
of UmuD92C, RecA, and SSB (17). Relatively weak, nonproc-
essive synthesis is catalyzed by pol III core alone (Fig. 1, lane
1). In the presence of b,g-complex plus SSB, synthesis by pol
III core becomes much more processive, terminating one base
before reaching the abasic site (Fig. 1, lane 2). Addition of
RecA, either to pol III core (Fig. 1, lane 3) or to pol III core,
b,g-complex, and SSB (Fig. 1, lane 4) stimulates each reaction,
but primer elongation still terminates at the X 2 1 position,
one base before the lesion.
The key observation is that addition of UmuD92C enables
significant bypass of the lesion, with continued synthesis to the
end of the template (Fig. 1, lane 5). The presence of an intense
pause band at X 2 1 suggests that incorporation opposite the
lesion is still rate limiting, although it is possible that this band
could arise by excision of a nucleotide incorporated opposite
the abasic site by the « proofreading exonuclease of pol III
core. The polymerization reaction leading up to the lesion and
beyond is essentially nonprocessive in the presence of
UmuD92C (Fig. 1, lane 5), although pol III and b,g-complex are
both present along with ATP. A summation of integrated band
intensities beyond the lesion (summed from site X 1 1 to the
end of the template) relative to the bands extended up to and
including the lesion (summed from site 1 to X) shows that the
amount of bypass observed after a 10 min incubation is '20%;
i.e., the amount of lesion bypass corresponds to 20% of the
total synthesis.
Either ATP or the nonhydrolyzable ATP analog adenosine
59-[gS]thiotriphosphate (ATPgS) is required for lesion bypass
(data not shown). ATP or ATP-[gS] is needed in the reaction
for loading b on DNA by g-complex (22), and also for binding
RecA to DNA (23), thus converting it to RecA*. ATP is
hydrolyzed throughout the reaction, resulting in a reduction to
60% of its initial level after a 10-min reaction (data not shown).
To verify that the initial input concentration of ATP (1 mM)
FIG. 1. UmuD92C-stimulated abasic site bypass. Standard polymer-
ization reactions, using a running-start protocol, were carried out in
the presence or absence of exogenous pol III core by using combina-
tions of UmuD92C, RecA, b,g-complex, and SSB. Four dNTPs (100
mM) and ATP (1 mM) were present in all reactions. A 32P-labeled
primer was annealed to a DNA template containing an abasic lesion,
X (top of figure), and the replication products were separated in 10%
denaturing polyacrylamide gels and visualized by phosphorimaging.
Locations of the unextended primer band, abasic site (X), upstream
site adjacent to the lesion (X 2 1), and the end of template are
indicated on the right. Lane P contains the primer in the absence of
proteins. Additions to the replication reaction mixtures are shown in
the box at the top of the gel; b 1 g, represents the b-clamp processivity
subunit of the pol III holoenzyme complex and the five protein
g-clamp loading complex consisting of the subunits g, d, d9, x, c.
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is sufficient to sustain the conversion of RecA 3 RecA*, we
added LexA protein to the reaction at 10 min and observed
RecA*-mediated cleavage of LexA (data not shown).
Optimal stoichiometries for each of the mutasome compo-
nents in catalyzing lesion bypass were determined to be: M13
DNA (2 nM), UmuD92C (200 nM), RecA (1 mM), pol III core
(in a range of 1–10 nM), b-sliding clamp (40 nM), g-clamp
loading complex (10 nM), SSB (300 nM as tetramer), ATP (1
mM). The conditions leading to efficient lesion bypass differ
in two important ways from those previously reported by using
renatured UmuC (16, 24). First, a molar ratio of 26UmuD9y
UmuC was required in the earlier study to observe a small
amount of bypass compared with the physiologically correct
value of 2 UmuD9yUmuC found for the soluble UmuD92C
complex used in the current study. This 13-fold difference
suggests that perhaps most of the renatured UmuC was not
biologically active. Polyethylene glycol (PEG) was required to
observe lesion bypass in the earlier study, perhaps as a
crowding agent to concentrate UmuC at the site of the lesion.
Our bypass assay is insensitive to PEG.
UmuD*2C Catalyzes RecA*-Dependent Lesion Bypass in the
Absence of Exogeneous Pol III Core. Unexpectedly, lesion
bypass was observed to occur in a ‘‘control’’ reaction contain-
ing UmuD92C, RecA, b,g-complex, and SSB, in the absence of
exogeneous pol III core (Fig. 1, lane 9). Lesion bypass does not
occur in the absence of either RecA (Fig. 1, lane 7) or
b,g-complex plus SSB (Fig. 1, lane 8). However, one interest-
ing difference in the gel band patterns is the appearance of two
adjacent bands just before the lesion (at X 2 1) and directly
opposite the abasic site (X) (Fig. 1, lanes 7 and 8). Thus, a band
corresponding to stable incorporation opposite the lesion
persists in the absence of added pol III core (in contrast to the
presence of pol III core, compare with Fig. 1, lanes 2–4).
Therefore, our UmuD92C preparation contains a weak pol
activity (Fig. 1, lane 6) which is stimulated in the presence of
RecA (Fig. 1, lane 8). We estimate that UmuD92C is at least
95% pure, based on the absence of contaminating bands on
silver-stained or Coomassie-stained polyacrylamide gels (data
not shown). The presence of pol I contamination can be ruled
out because primer extension is unaltered when polymeriza-
tion occurs in the presence of a potent neutralizing pol I
antibody (data not shown). However, we cannot rule out the
presence of trace levels of either pol III or pol II, despite the
fact that the UmuD92C complex was purified by gel filtration.
We have verified that the UmuD92C complex migrates with an
expected molecular mass of 70 kDa, indicating that it is
unlikely to be directly bound to a pol. It is therefore much more
likely that pol II, whose molecular mass is 89.9 kDa (25), is
present as a contaminating pol, rather than either pol III core
(167.5 kDa) or pol III a-subunit (130 kDa) (26). However, we
cannot yet eliminate the possibility that UmuD92C might itself
contain an intrinsic, low fidelity, pol activity. UmuD9 and C
exhibit no significant sequence similarity to any of the known
pols, although UmuC is weakly homologous to yeast Rev1,
which incorporates dCMP opposite abasic sites (27).
A strain of E. coli carrying the recA1730 mutation (S117F)
is proficient for most of RecA’s activities but is specifically
defective for Umu-dependent mutagenesis (8, 10, 28), proba-
bly because RecA1730 is unable to target the Umu proteins to
lesion-containing DNA (29). Although DNA synthesis con-
tinues to take place when wild-type RecA protein is replaced
with purified RecA1730, bypass of the abasic lesion no longer
occurs (Fig. 1, lane 10). Instead, the primer is extended one
base prior to the lesion, with a much smaller amount of
incorporation occurring directly opposite the lesion. These
data are in contrast to the lesion bypass promoted by wild-type
RecA protein (Fig. 1, lanes 5 and 9), but are consistent with the
activity of RecA1730 in vivo (8, 10), and in vitro (29).
The Effect of Pol III and Pol II on Lesion Bypass. We have
measured lesion bypass as a function of the concentration of
three DNA pols, pols III, II, and a-subunit, in the presence of
a fixed concentration of UmuD92C (Fig. 2). The primer 39 end
is located one base before the abasic lesion allowing incorpo-
ration of a single nucleotide opposite X from a standing start
(Fig. 2 Upper).
In reactions containing UmuD92C, preincubations were car-
ried out for 4 min in the presence of b,g-complex, SSB, ATP
(1 mM) and two dNTPs, dCTP (100 mM), and dATP (100
mM). dCTP is present to protect against primer degradation by
pol-associated exonuclease activity; dATP can be incorporated
opposite X, but can only be extended by formation of down-
stream mispairs (see Fig. 3A, UmuD92C panel, lane A). After
preincubation, the three pols were added, along with dTTP
(100 mM) and dGTP (100 mM), in separate reactions. An
increase in the amount of intermediate and full-length prod-
ucts occurs with increasing concentrations of pol in the pres-
ence of UmuD92C (Fig. 2). However, the fraction of primers
extended opposite the lesion and beyond actually decreases
from about 40% to roughly 25% as the concentrations of pol
III core and pol II increase from 0 to 20 nM and 10 nM,
respectively (Fig. 2). The decrease in the fraction of extended
primers is caused by pol III core and pol II proofreading
occurring primarily at the lesion site (X) and at the downstream
X 1 1 site (pol III core and pol II panels, lanes 3 and 4). In
contrast, there is no reduction in gel band intensities at X and
X 1 1 by using nonproofreading pol III a (pol III a panel, lanes
3 and 4), whereas the fraction of primers extended opposite
and beyond the lesion increases rather than decreases (Fig. 2).
Bypass in the absence of UmuD92C increases as the levels of
pol are increased. For the case of pol III core and a-subunit,
a small amount of bypass is observed at 20 nM enzyme
concentrations (Fig. 2, lane 7), with barely detectable full-
length product DNA formed at 20 nM pol concentrations (Fig.
2). A larger amount of full-length product is made by pol II.
The key point to emphasize is that synthesis opposite the lesion
and beyond is reduced significantly for all three pols when
UmuD92C is absent from the reaction (Fig. 2, 2UmuD92C, lanes
5–7).
FIG. 2. Effect of pol III and pol II on translesion replication.
Standard polymerization reactions, using a standing-start protocol,
were carried out in either the presence or absence of UmuD92C by using
different concentrations of pol III core (0, 0.5, 2, 20 nM), pol III
a-subunit (0, 0.5, 2, 20 nM), and pol II (0, 0.2, 1, 10 nM). All reactions
contain RecA, b,g-complex, SSB, four dNTPs (100 mM), and ATP (1
mM). Lane P contains the 32P-labeled primer in the absence of
proteins. Locations of the unextended primer band, abasic site (X),
downstream site adjacent to the lesion (X 1 1), and end of template
are indicated on the right. The DNA used in the standing-start
protocol is shown at the top.
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In a reciprocal experiment, in which the concentration of
UmuD92C was varied (at fixed pol concentration), we observed
an increase in bypass efficiencies as UmuD92C concentration is
increased, with maximum bypass occurring at a molar ratio of
100 UmuD92Cy1 primer-template DNA (pyt DNA) (data not
shown). A shallow inhibition ('30%) in bypass occurs at
higher concentrations of UmuD92C in the range of 200 nM to
1 mM, which is possibly caused by interactions taking place
between UmuD92C and RecA bound to DNA downstream of
the replication fork (ref. 17; W. M. Rehrauer, I.B. R.W.,
M.F.G., and S. C. Kowalczykowski, unpublished data). The
data in Fig. 2 demonstrate that UmuD92C is able to stimulate
incorporation opposite the lesion and the addition of one or
more nucleotides beyond the lesion.
For a-subunit, the band intensities at X and X 1 1 (one base
downstream from the lesion) remain constant as a is varied
between 0 and 20 nM (Fig. 2, a-subunit panel, 1 UmuD92C
lanes). Therefore, in the absence of the «-exonuclease subunit,
the incorporation at X and X 1 1 is essentially independent of
pol concentration, depending primarily on the concentration
of UmuD92C. An increase in full-length product at increased
levels of a suggests that the pol displaces UmuD92C and
continues synthesis downstream from the lesion. A similar
conclusion can be drawn from the data with pol III core, and
also from experiments in which the pols and UmuD92C are both
present when the reaction is initiated by addition of all four
dNTPs (data not shown).
UmuD*2C-Stimulated Base Misincorporation and Mismatch
Extension at Aberrant and Normal Template Sites. A clear
illustration of the marked reduction in pol fidelity in the
presence of UmuD92C is seen when incorporation at aberrant
and normal template sites is carried out by using just one dNTP
substrate (Fig. 3). A standing-start protocol is used to measure
incorporation at an abasic lesion, X (Fig. 3A) or at a normal
template T (Fig. 3B). All reactions contain RecA, b,g-
complex, SSB, and ATP (1 mM), and either pol III core, pol
II, or UmuD92C. The levels of pol III core (1 nM) and pol II
(0.2 nM) were chosen to give similar (or greater) amounts of
synthesis than UmuD92C (200 nM, in the absence of exoge-
neous pol), on an undamaged DNA template with the four
dNTPs present (Fig. 3B, compare lanes 4 for the three panels).
There is essentially no stable incorporation catalyzed by pol
III (1 nM) opposite X by using either a single dNTP or in the
presence of all four dNTPs (a faint band is seen in lanes A and
4, representing a small incorporation of dAMP). For pol II (0.2
nM), faint bands are observed for incorporation of dGMP,
dAMP, and dTMP, but not dCMP. Pol II catalyzes a small
amount of full-length product in the presence of all four
dNTPs, consistent with our previous demonstration that pol II
can copy past abasic lesions with a substantially higher effi-
ciency than pol III (30).
Synthesis carried out with UmuD92C in the presence of only
dGTP or dATP substrates results in the incorporation of five
consecutive G’s or A’s, whereas synthesis with either dTTP or
dCTP results in the incorporation of either three T’s or one C
(Fig. 3A). The results are similar in the presence or absence of
exogenous pol (data not shown).
The first incorporation occurs opposite the abasic lesion.
Synthesis taking place at template sites downstream from the
lesion correspond mainly to the incorporation of mismatched
nucleotides, followed by extension of mismatched termini and
by additional misincorporations. A much larger amount of
synthesis occurs in the presence of four dNTPs (Fig. 3A, lane
4). The weak primer extension band observed in the absence
of dNTPs (Fig. 3, UmuD92C panel, lane 0) is caused by
incorporation of ribo AMP. These results stand in marked
contrast to the relatively weak primer extension catalyzed by
pol III and pol II, in the absence of UmuD92C, and clearly
demonstrate the remarkable effect of UmuD92C in relaxing the
specificity of nucleotide incorporation at aberrant and normal
template sites.
FIG. 3. Effect of UmuD92C on nucleotide misincorporation and mismatch extension on lesion-containing and normal DNA templates. Standard
standing-start polymerization reactions were carried out by using pol III core, pol II, or UmuD92C. (A) Reactions carried out by using a DNA
template containing an abasic lesion, X. (B) Reactions carried out by using a natural DNA template in which X is replaced by T. The lanes labeled
as G, A, T, and C denote reactions carried out with a single dNTP substrate, dGTP, dATP, dTTP, and dCTP, respectively. The lanes labeled as
4 and 0 denote reactions carried out in the presence and absence of four dNTPs, respectively. Lane P contains the 32P-labeled primer in the absence
of proteins. The abasic lesion containing and natural DNA templates are shown above each gel. A portion of each template sequence is shown
on the right. UmuD92C measurements made in the presence of pol III (1 nM) and pol II (0.2 nM), resulted in banding patterns identical to those
shown in the UmuD92C panel.
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Given the paucity of incorporation by pol III and pol II on
the abasic template, it is important to show that these pols
carry out normal DNA synthesis on a normal template, in
which X is replaced by T (Fig. 3B). As expected, the predom-
inant reaction for pol III and pol II is the incorporation of
dAMP opposite T when dATP is the only substrate present. A
small amount dTMP misincorporation is also occurring, pos-
sibly by a transient misalignment mechanism involving the
downstream template A (31). In the case of UmuD92C, either
four G’s, four A’s, three T’s, two C’s, or two ribo A’s are
incorporated (Fig. 3B), indicating that the mutagenic Umu
complex stimulates misincorporations and mismatch exten-
sions on natural DNA templates as well as those containing
DNA damage.
Although the data in Fig. 3 appear to suggest that the
nucleotide specificities revealed in the single dNTP experi-
ments for the UmuD92C complex is clearly distinct from either
pol II or pol III, leaving open the possibility that Umu might
contain a distinct polymerizing component, such altered pol
specificities could also be accounted for by an alteration of pol
properties while interacting with UmuD92C. We intend to
resolve this issue by studying UmuD92C purified from polB null
and polC temperature-sensitive strains.
DISCUSSION
Despite our ever-increasing understanding of the SOS re-
sponse and its many repair pathways, little is known about the
biochemical mechanisms of SOS mutagenesis (1, 32). Most of
our knowledge is based on genetic data which indicate that
UmuC, UmuD9, RecA, and pol III holoenzyme are involved in
SOS mutagenesis (2), perhaps as a ‘‘mutasome’’ complex (4).
The basic principle underlying translesion DNA synthesis is
that a replication fork stalls when encountering a DNA
damage site, and that SOS-induced UmuC, UmuD9, and
RecA* proteins interact with pol III to shepherd it past a
template lesion, resulting primarily in a base substitution
mutation at the lesion site (33). The principal difficulty in
investigating the biochemical basis of SOS lesion bypass stems
from problems in purifying biologically active UmuC protein,
which is inherently insoluble in aqueous solution when over-
produced (15).
Echols and coworkers (16) were the first to observe UmuC–
UmuD9-dependent lesion bypass by using a preparation of
UmuC that was purified in a denatured state in the presence
of 8 M urea and subsequently renatured (15, 24). There were
several major difficulties working with renatured UmuC,
including small yields of renatured soluble protein, poor
signal-to-noise in the bypass reaction, variability in the con-
ditions for bypass: some preparations showing bypass with
activated wild-type RecA protein whereas others did not (24).
Owing to uncertainties in the biological activity of refolded
UmuC protein and to circumvent the problems relating to
insoluble UmuC protein, we purified sizable quantities of
soluble UmuC tightly complexed to UmuD9 (17).
Reconstitution of a UmuD*2C–RecA-Dependent SOS Lesion
Bypass System in Vitro. Lesion bypass occurs as a two-step
reaction with a nucleotide initially incorporated opposite the
lesion, followed by extension from a distorted primer terminus.
Both steps involve aberrant synthetic reactions which pols
catalyze at greatly reduced efficiencies (about 1024- to 1025-
fold) compared with normal synthetic reactions (34, 35).
In our in vitro system, bypass of an abasic lesion depends on
the presence of UmuD92C, RecA*, b-sliding clamp, g-clamp-
loading complex, and SSB (Fig. 1). When either UmuD92C or
RecA* is excluded from the reaction, synthesis terminates at
the X 2 1 template position, one base prior to reaching the
abasic lesion, X, indicating that both bypass steps require the
presence of UmuD92C and RecA* (Fig. 1, lanes 5 and 9). A
model by Bridges and Woodgate (13) posits that pol III can, by
itself, incorporate a nucleotide opposite a lesion, but cannot
catalyze bypass in the absence of UmuD9 and UmuC proteins
(36). However, recent data show that replacement of umuDC
by either mucAB or rumAB alters the mutational specificity at
T–T cyclobutane dimers, suggesting that the UmuD92C com-
plex might also influence pol insertion specificities in addition
to modulating bypass (37).
Requirement for RecA*, SSB, and b,g-Complex During
Lesion Bypass. RecA protein plays a direct role in catalyzing
SOS mutagenesis beyond its involvement in cleavage of LexA
and UmuD proteins (7–9, 29). Omission of wild-type RecA
(Fig. 1, lanes 6 and 7) or the addition of RecA1730 (Fig. 1, lane
10), a missense mutant refractory to Umu-dependent mu-
tagenesis, resulted in no detectable bypass. These observations
are, therefore, entirely consistent with the genetic data and
lend credence to the biological relevance of the reconstitution
assay.
SSB protein was also essential for bypass. Such a require-
ment may be indirect because SSB eliminates DNA secondary
structure, keeps the b-clamp from sliding off linear DNA (21),
and helps RecA achieve its activated state (23). However,
because MucB, a homolog of UmuC, was shown to interact
directly with SSB in a yeast two-hybid assay (38), perhaps
lesion bypass is stimulated by a direct UmuC–SSB interaction.
A requirement for b,g-complex in the bypass assay might be to
increase the residence time of the mutasome at the lesion site.
UmuD*2C-Stimulated Lesion Bypass in the Presence of Pol
III and Pol II. Although our preparation of UmuD92C appears
to be .95% pure, we nevertheless observed significant primer
elongation in the absence of exogeneous DNA pol (Fig. 1,
UmuD92C). Optimal lesion bypass on the M13 DNA template
requires the presence of a 100-fold molar excess UmuD92C (200
nM UmuD92C: 2 nM pyt DNA). We determined that the rate
of DNA synthesis observed with UmuD92C corresponds to
about 1 nM pol III core or less than 0.2 nM pol II (Fig. 3B, lanes
4). Thus, contamination of UmuD92C with 0.5% pol III core or
,0.1% pol II, minute levels which would not show up on either
Coomassie or silver-stained polyacrylamide gels, could ac-
count for DNA synthesis in the absence of exongenous pol.
Contamination with pol I was ruled out by using a potent pol
I neutralizing antibody. It is unlikely that UmuD92C is bound to
either pol III, pol III a-subunit, or pol II, because the Umu
complex migrates with its expected molecular mass of 70 kDa
based on Sephadex gel filtration in 1 M salt (17).
The weak, possibly adventitious, pol activity was titrated out
by adding a large excess of purified pol in the assay, enabling
us to examine the effect of UmuD92C-stimulated bypass in the
presence of pol III or pol II. By using up to a 20-fold excess of
pol III core and pol II, we determined that the percentage of
lesion bypass actually decreased by about a factor of two with
increasing pol III activities (Fig. 2), attributable to proofread-
ing at the lesion site and at a site one base downstream from
the lesion. Despite the decrease in the percentage of lesion
bypass with increasing concentrations of pol III core and pol
II, there is a marked increase in the synthesis of intermediate-
and full-length product DNA (Fig. 2), suggesting that pol III
core or pol II can bind to primers that have been extended past
the lesion for continued synthesis along an undamaged region
of the template.
The principal conclusion to be drawn from the pol titration
measurements is that both lesion bypass reactions, incorpora-
tion opposite the lesion and extension past the lesion, are
determined by the action of the UmuD92C and RecA* proteins,
rather than by pol III, a-subunit, or pol II, because lesion
bypass is reduced significantly for each pol in the absence of
UmuD92C (Fig. 2). Conversely, when the concentration of
UmuD92C is varied at a fixed pol concentration, the efficiency
of bypass increases, reaching a maximum value at a ratio of
about 100 UmuD92C to 1 pyt DNA.
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Effects of UmuD*2C on DNA Synthesis Fidelity and Proces-
sivity. Synthesis on undamaged DNA before encountering a
lesion is stimulated in the presence of UmuD92C and RecA*
(Fig. 1). However, in contrast to processive synthesis carried
out by pol III core plus b,g-complex, synthesis in the presence
of UmuD92C is distributive both upstream and downstream
from the site of the lesion either in the presence or absence of
exogenous pol III core (Fig. 1).
Perhaps the most noteworthy property of UmuD92C is re-
f lected in its ability to stimulate nucleotide misincorporation
and mismatch extension at aberrant and normal template sites.
This property is illustrated vividly in an experiment in which
just a single dNTP is present for incorporation at an abasic site
(Fig. 3A) or at a normal T (replacing the abasic site), in the
same sequence context (Fig. 3B). UmuD92C stimulates incor-
poration of each dNTP substrate opposite the lesion (including
incorporation of riboA), and causes multiple misincorpora-
tions downstream from the the lesion, whereas pol III core and
pol II catalyze negligible incorporation either at the abasic site
or beyond (Fig. 3A). In a similar vein, UmuD92C stimulates
misincorporations opposite a normal template T site and
beyond, whereas pol III core and pol II predominantly incor-
porate only A opposite T (Fig. 3B).
These data illustrate how the Umu complex can be involved
in both SOS-targeted and untargeted mutagenesis. In the case
of mutagenesis targeted to the site of a lesion, UmuD92C causes
a reduction in polymerization fidelity leading to an increase in
misincorporation opposite the lesion and to a stimulation of
extension past the lesion by using an aberrant primer teminus.
In a recent study, it was demonstrated that SOS-dependent
spontaneous mutator activity reflects the processing of repli-
cation errors containing normal bases, rather than errors
opposite cryptic lesions (39). Indeed, extension of natural base
mispairs occurs with efficiencies of about 1024 to 1025 com-
pared with extension of correctly matched base pairs (40, 41),
and thus presents a strong kinetic block to further elongation.
Therefore, the role of the UmuD92C proteins in SOS mutagen-
esis may be to serve as generalized ‘‘elongation’’ factors that
are used by the cell to extend any kinetically unfavorable
primer terminus junction, not just those at a DNA lesion.
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